Abiraterone is a pharmaceutical raw material used in the manufacturing of medications for prostate cancer. It is an active pharmaceutical ingredient that is typically formulated with a corticosteroid for therapeutic use.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 154229-19-3
(3?)-16-[(3?)-3-Hydroxyandrosta-5,16-dien-17-yl]-17-(3-pyridinyl)-androsta-5,16-dien-3-ol
pharmaceutical raw material
3-Deoxy-3-chloroabiraterone (Mixture of Diastereomers)
pharmaceutical raw material
Anhydro Abiraterone
pharmaceutical raw material
Δ4-abiraterone
pharmaceutical raw material
Pyridine, 2-(2-(methylamino)ethyl)-, hydrochloride
pharmaceutical raw material
Almotriptan
pharmaceutical raw material
(3ss)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol-d4; CB 7598-d4;
pharmaceutical raw material
Abiraterone Impurity 54
research compound
(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol
GZOSMCIZMLWJML-VJLLXTKPSA-N
C[C@]12CC[C@@H](CC1=CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC=C4C5=CN=CC=C5)C)O